Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TECZEM | Bausch Health Companies | N-020507 DISCN | 1996-10-04 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
EPANED | Azurity | N-208686 RX | 2016-09-20 | 1 products, RLD, RS |
VASOTEC | Bausch Health Companies | N-018998 RX | 1985-12-24 | 4 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LEXXEL | AstraZeneca | N-020668 DISCN | 1996-12-27 | 2 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VASERETIC | Bausch Health Companies | N-019221 RX | 1986-10-31 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
enalapril maleate | ANDA | 2024-01-18 |
enalapril maleate and hydrochlorothiazide | ANDA | 2023-12-08 |
enalapril maleate oral solution | ANDA | 2023-12-27 |
enalaprilat | ANDA | 2024-01-04 |
epaned | New Drug Application | 2020-07-27 |
vaseretic | New Drug Application | 2020-08-31 |
vasotec | New Drug Application | 2018-11-12 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Enalapril Maleate, Epaned, Azurity | |||
9669008 | 2036-03-25 | DP | |
9808442 | 2036-03-25 | U-3, U-71, U-185, U-1723, U-1892 | |
10039745 | 2036-03-25 | DP | |
10154987 | 2036-03-25 | U-3, U-71, U-185, U-1723, U-1892 | |
10772868 | 2036-03-25 | DP | |
10786482 | 2036-03-25 | DP | |
11040023 | 2036-03-25 | DP | |
11141405 | 2036-03-25 | DP | |
11173141 | 2036-03-25 | DP | |
Enalapril Maleate, Epaned Kit, Silvergate Pharms | |||
8568747 | 2032-11-06 | DP | |
8778366 | 2032-11-06 | U-3, U-71, U-185, U-1723, U-1892 | |
9855214 | 2032-11-06 | DP | |
9968553 | 2032-11-06 | U-3, U-71, U-185, U-1723, U-1892 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 2 | 6 | 13 | 14 | 9 | 42 |
Heart failure | D006333 | HP_0001635 | I50 | 1 | 5 | 15 | 13 | 2 | 33 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | 3 | 4 | 3 | — | 10 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | 1 | 2 | 2 | 6 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | 2 | 1 | 1 | 2 | 5 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 2 | 2 | 1 | — | 5 |
Essential hypertension | D000075222 | — | I10 | 1 | 3 | — | 2 | — | 5 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | — | 1 | 3 | 5 |
Dilated cardiomyopathy | D002311 | HP_0001644 | I42.0 | — | 3 | 3 | 1 | — | 5 |
Covid-19 | D000086382 | — | U07.1 | — | — | 2 | 1 | 1 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 2 | — | 3 | 5 |
Congenital heart defects | D006330 | HP_0001627 | Q24.9 | — | 2 | 4 | — | — | 4 |
Proteinuria | D011507 | HP_0000093 | R80 | — | — | 1 | — | 2 | 3 |
Coronary disease | D003327 | — | — | — | 1 | 2 | — | 1 | 3 |
Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | 1 | — | 1 | — | — | 2 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | 1 | — | 1 | 2 |
Ischemic stroke | D000083242 | — | — | — | — | 1 | — | 1 | 2 |
Neoplasms | D009369 | — | C80 | — | — | 2 | — | — | 2 |
Pneumonia | D011014 | EFO_0003106 | — | — | — | 1 | — | — | 1 |
Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cerebral hemorrhage | D002543 | — | — | — | 2 | — | — | 2 | 4 |
Blood pressure | D001794 | EFO_0004325 | — | — | 2 | — | — | — | 2 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | 1 | — | — | — | 1 |
Hyperlipidemias | D006949 | HP_0003077 | E78.5 | — | 1 | — | — | — | 1 |
Melanoma | D008545 | — | — | — | 1 | — | — | — | 1 |
Glomerulonephritis | D005921 | HP_0000099 | N05 | — | 1 | — | — | — | 1 |
Membranoproliferative glomerulonephritis | D015432 | — | — | — | 1 | — | — | — | 1 |
Vascular diseases | D014652 | EFO_0004264 | I77 | — | 1 | — | — | — | 1 |
Isolated systolic hypertension | D000092244 | — | — | — | 1 | — | — | — | 1 |
Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Barrett esophagus | D001471 | EFO_0000280 | K22.7 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | — | 1 | 1 |
Lupus nephritis | D008181 | EFO_0005761 | — | — | — | — | — | 1 | 1 |
Fabry disease | D000795 | Orphanet_324 | E75.21 | — | — | — | — | 1 | 1 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | — | — | 1 | 1 |
Unstable angina | D000789 | EFO_1000985 | I20.0 | — | — | — | — | 1 | 1 |
Hypertrophic cardiomyopathy | D002312 | EFO_0000538 | I42.1 | — | — | — | — | 1 | 1 |
Endocrine system diseases | D004700 | EFO_0001379 | E34.9 | — | — | — | — | 1 | 1 |
Prehypertension | D058246 | — | — | — | — | — | — | 1 | 1 |
Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 1 | 1 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | — | — | 1 | 1 |
Drug common name | Enalapril |
INN | enalapril |
Description | Enalapril is a dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration). It has a role as a prodrug, an EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor, an antihypertensive agent and a geroprotector. It is a dicarboxylic acid monoester and a dipeptide. It is functionally related to an enalaprilat (anhydrous). |
Classification | Small molecule |
Drug class | narcotic agonists/antagonists (normorphine type); antihypertensives (ACE inhibitors) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O |
PDB | — |
CAS-ID | 75847-73-3 |
RxCUI | — |
ChEMBL ID | CHEMBL578 |
ChEBI ID | 4784 |
PubChem CID | 5388962 |
DrugBank | DB00584 |
UNII ID | 69PN84IO1A (ChemIDplus, GSRS) |